Clinical Trial Update: Use of Colchicine to Decrease Atrial Fibrillation Recurrence After Ablation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating colchicine to reduce atrial fibrillation recurrence after ablation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Stony Brook University | Conditions: Atrial Fibrillation | Phase 3 | Status: UNKNOWN